| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/30/2009 | US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 07/30/2009 | US20090192164 Treating agent of inflammatory bowel disease |
| 07/30/2009 | US20090192161 Amorphous and Crystalline Forms of Aprepitant and Processes for the Preparation Thereof |
| 07/30/2009 | US20090192160 Compounds |
| 07/30/2009 | US20090192159 Substituted gamma lactams as therapeutic agents |
| 07/30/2009 | US20090192156 Phthalazinone derivatives |
| 07/30/2009 | US20090192151 Therapeutic amides and related compounds |
| 07/30/2009 | US20090192143 Substituted diazepan orexin receptor antagonists |
| 07/30/2009 | US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | US20090192134 Compounds |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | DE102008006005A1 New N-azinyl-N'-pyridylsulfonyl-urea compounds useful e.g. as herbicide, plant growth regulator and plant protection regulator and to combat undesirable plant growth e.g. Agrostis in special plant cultures e.g. wheat, barley and rye |
| 07/30/2009 | DE102007057718A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 07/30/2009 | CA2712998A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712777A1 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | CA2712750A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | CA2712685A1 Novel heterocyclic compounds |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083006A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| 07/29/2009 | EP2082740A2 Use of imidazole derivatives as MDR modulators |
| 07/29/2009 | EP2081923A1 Certain substituted amides, method of making, and method of use thereof |
| 07/29/2009 | EP2081918A2 Mitotic kinesin inhibitors and methods of use thereof |
| 07/29/2009 | EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds |
| 07/29/2009 | EP2081572A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 07/29/2009 | EP1786807B1 Heterocyclic antiviral compounds |
| 07/29/2009 | EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 07/29/2009 | EP1601671B1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 07/29/2009 | CN101495475A Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives |
| 07/29/2009 | CN101492416A Compounds effecting glucokinase |
| 07/29/2009 | CN100519572C Isoxazoline derivatives as P, N ligands |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/28/2009 | US7566789 2-[2-(5-chlorothiophen-2-yl)-1H-benzimidazol-5-yl]-N-[4-(3-oxomorpholin-4-yl)phenyl]acetamide; anticoagulants of blood factor Xa; treating thromboembolic diseases, thrombosis; antitumor agent for treating of tumours |
| 07/28/2009 | US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 07/28/2009 | US7566782 Process for the preparation of rosuvastatin |
| 07/28/2009 | US7566780 Phosphorus-based oxazine compounds and preparation method of the same |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566732 5-(1H-benzimidazol-2-ylmethylene)-3-(4-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one; ubiquitin ligase (synthetase) inhibitors; inhibit ubiquitination of target proteins; poxviruses; herpesviruses; retroviruses; variola viruses; smallpox; hemorrhagic smallpox; HIV; vaccines; side effect reduction |
| 07/28/2009 | US7566730 Substituted aminoethers for the treatment of Alzheimer's disease |
| 07/28/2009 | US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | US7566712 Biaryl piperazinyl-pyridine analogues |
| 07/28/2009 | US7566709 4-(3-(2-Fluorophenyl)-1-phenyl-1H-pyrazol-4-ylmethyl)morpholine; 5HT2A/5HT2C receptors; central nervous system; schizophrenia; antidepressants; dementia; Parkinson's disease; Azheimer's disease; Huntington's disease; Tourette's syndrome; anxiolytic agents; congnition activators; analgesics |
| 07/28/2009 | US7566683 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 07/23/2009 | WO2009091760A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009091759A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | WO2009090548A2 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands |
| 07/23/2009 | WO2009090239A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | WO2009089851A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 07/23/2009 | WO2008103351A3 Heterocyclic aspartyl protease inhibitors |
| 07/23/2009 | US20090187031 compounds which mimic the chemical and biological activity of discodermolide; may have use as anticancer agent |
| 07/23/2009 | US20090187021 Indane compounds as ccr5 antagonists |
| 07/23/2009 | US20090186927 Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186911 (RS)-S-[3-({[6-Bromo-4-(isopropylamino)quinazolin-7-yl]oxy}methyl)phenyl] N-(ethoxycarbonyl)-S-ethylsulphoximide, used for the treatment of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, asthma and multiple sclerosis |
| 07/23/2009 | US20090186909 Oxadiazolidinedione Compound |
| 07/23/2009 | US20090186905 Anaplastic lymphoma kinase modulators and methods of use |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186894 N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use |
| 07/23/2009 | US20090186893 inositol requiring enzyme 1 (IRE-1 alpha) inhibitors such as 2-hydroxy-6-(5-(4-methylpiperazine-1-carbonyl)thiophen-2-yl)-1-naphthaldehyde, relieve protein folding stress by enhancing molecular chaperone activity and protects cells from stress induced apoptosis; autoimmune diseases; anticancer; viricides |
| 07/23/2009 | US20090186891 Organic compounds |
| 07/23/2009 | US20090186886 Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments |
| 07/23/2009 | US20090186885 Therapeutic compounds |
| 07/23/2009 | US20090186884 such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders |
| 07/23/2009 | US20090186876 Pyridine Analogues II |
| 07/23/2009 | US20090186875 Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer |
| 07/23/2009 | US20090186872 Loxapine analogs and methods of use thereof |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186869 Antiviral compounds |
| 07/23/2009 | US20090186083 Method for stabilization of isoxazole compound |
| 07/23/2009 | US20090185999 Derivatives of gefitinib |
| 07/23/2009 | CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712190A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2711708A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | EP2080757A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 07/22/2009 | EP2079734A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 07/22/2009 | EP2079731A1 Novel substituted piperidyl-propane-thiols |
| 07/22/2009 | EP2079730A1 Mglur5 modulators |
| 07/22/2009 | EP2079729A1 Compounds and compositions as protein kinase inhibitors |
| 07/22/2009 | EP2079709A1 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 07/22/2009 | EP2079703A1 Indazole derivatives useful as l-cpt1 inhibitors |
| 07/22/2009 | EP2079701A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 07/22/2009 | EP2079699A1 Quinoline derivatives |
| 07/22/2009 | EP2079695A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 07/22/2009 | EP2079693A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 07/22/2009 | EP2079690A2 3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/22/2009 | EP2079307A2 Farnesoid x receptor agonists |
| 07/22/2009 | EP2006286A9 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | EP1678169B1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |